Midcap Stocks Research: Subscribe for 1 Year... Get Access for 3 Years
Here is the latest financial fact sheet of TATVA CHINTAN PHARMA. For more details, see the TATVA CHINTAN PHARMA quarterly results and TATVA CHINTAN PHARMA share price.
1 Day | % | -2.1 |
No. of shares | m | 23.39 |
1 Week | % | -5.0 |
1 Month | % | -8.4 |
1 Year | % | -30.2 |
52 week H/L | Rs | 1,888.1/1,063.4 |
No. of Mths Year Ending |
12 Mar-19* |
12 Mar-20* |
12 Mar-21* |
12 Mar-22* |
12 Mar-23* |
5-Yr Chart Click to enlarge
|
---|
TATVA CHINTAN PHARMA EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | NA | NA | NA | 2,976 | 2,649 | |
Low | Rs | NA | NA | NA | 2,001 | 1,606 | |
Sales per share (Unadj.) | Rs | 256.6 | 327.4 | 149.5 | 195.6 | 191.1 | |
Earnings per share (Unadj.) | Rs | 25.6 | 47.0 | 26.0 | 43.2 | 20.5 | |
Diluted earnings per share | Rs | 8.8 | 16.2 | 22.3 | 41.0 | 19.4 | |
Cash flow per share (Unadj.) | Rs | 30.5 | 53.0 | 29.4 | 46.9 | 24.8 | |
Dividends per share (Unadj.) | Rs | 0 | 0 | 5.00 | 2.00 | 2.00 | |
Adj. dividends per share | Rs | 0.00 | 0.00 | 4.29 | 1.90 | 1.90 | |
Avg Dividend yield | % | 0 | 0 | 0 | 0.1 | 0.1 | |
Book value per share (Unadj.) | Rs | 99.1 | 146.4 | 82.6 | 213.4 | 232.2 | |
Adj. book value per share | Rs | 34.1 | 50.3 | 70.9 | 202.2 | 220.1 | |
Shares outstanding (eoy) | m | 8.04 | 8.04 | 20.09 | 22.17 | 22.17 | |
Price / Sales ratio | x | 0 | 0 | 0 | 12.7 | 11.1 | |
Avg P/E ratio | x | 0 | 0 | 0 | 57.5 | 103.7 | |
P/CF ratio (eoy) | x | 0 | 0 | 0 | 53.0 | 85.7 | |
Price / Book Value ratio | x | 0 | 0 | 0 | 11.7 | 9.2 | |
Dividend payout | % | 0 | 0 | 19.2 | 4.6 | 9.7 | |
Avg Mkt Cap | Rs m | 0 | 0 | 0 | 55,150 | 47,157 | |
Total wages/salary | Rs m | 163 | 205 | 238 | 308 | 386 |
TATVA CHINTAN PHARMA INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 2,063 | 2,632 | 3,004 | 4,336 | 4,236 | |
Other income | Rs m | 5 | 14 | 52 | 90 | 57 | |
Total revenues | Rs m | 2,068 | 2,646 | 3,056 | 4,427 | 4,294 | |
Gross profit | Rs m | 349 | 553 | 667 | 1,085 | 572 | |
Depreciation | Rs m | 40 | 48 | 67 | 82 | 96 | |
Interest | Rs m | 39 | 43 | 44 | 52 | 86 | |
Profit before tax | Rs m | 274 | 476 | 607 | 1,041 | 448 | |
Minority Interest | Rs m | 0 | 0 | 0 | 0 | 0 | |
Prior Period Items | Rs m | 0 | 0 | 0 | 0 | 0 | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Tax | Rs m | 69 | 98 | 84 | 82 | -7 | |
Profit after tax | Rs m | 205 | 378 | 523 | 959 | 455 | |
Gross profit margin | % | 16.9 | 21.0 | 22.2 | 25.0 | 13.5 | |
Effective tax rate | % | 25.0 | 20.6 | 13.9 | 7.9 | -1.6 | |
Net profit margin | % | 10.0 | 14.4 | 17.4 | 22.1 | 10.7 |
TATVA CHINTAN PHARMA BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 1,144 | 1,327 | 1,946 | 4,356 | 3,136 | |
Current liabilities | Rs m | 727 | 877 | 1,284 | 1,712 | 2,361 | |
Net working cap to sales | % | 20.2 | 17.1 | 22.1 | 61.0 | 18.3 | |
Current ratio | x | 1.6 | 1.5 | 1.5 | 2.5 | 1.3 | |
Inventory Days | Days | 1 | 0 | 0 | 2 | 3 | |
Debtors Days | Days | 73 | 69 | 110 | 48 | 73 | |
Net fixed assets | Rs m | 731 | 1,162 | 1,306 | 2,137 | 4,304 | |
Share capital | Rs m | 80 | 80 | 201 | 222 | 222 | |
"Free" reserves | Rs m | 717 | 1,097 | 1,459 | 4,509 | 4,926 | |
Net worth | Rs m | 797 | 1,177 | 1,660 | 4,731 | 5,148 | |
Long term debt | Rs m | 315 | 387 | 268 | 131 | 42 | |
Total assets | Rs m | 1,875 | 2,489 | 3,252 | 6,493 | 7,439 | |
Interest coverage | x | 7.9 | 12.2 | 14.6 | 20.9 | 6.2 | |
Debt to equity ratio | x | 0.4 | 0.3 | 0.2 | 0 | 0 | |
Sales to assets ratio | x | 1.1 | 1.1 | 0.9 | 0.7 | 0.6 | |
Return on assets | % | 13.1 | 16.9 | 17.4 | 15.6 | 7.3 | |
Return on equity | % | 25.8 | 32.1 | 31.5 | 20.3 | 8.8 | |
Return on capital | % | 28.2 | 33.2 | 33.8 | 22.5 | 10.3 | |
Exports to sales | % | 70.5 | 756.0 | 54.6 | 84.0 | 76.2 | |
Imports to sales | % | 27.6 | 352.9 | 22.1 | 37.9 | 56.9 | |
Exports (fob) | Rs m | 1,455 | 19,901 | 1,639 | 3,642 | 3,229 | |
Imports (cif) | Rs m | 570 | 9,289 | 663 | 1,644 | 2,409 | |
Fx inflow | Rs m | 1,455 | 19,901 | 1,639 | 3,642 | 3,229 | |
Fx outflow | Rs m | 570 | 9,289 | 663 | 1,644 | 2,409 | |
Net fx | Rs m | 885 | 10,612 | 976 | 1,998 | 820 |
TATVA CHINTAN PHARMA CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | 74 | 253 | 197 | 202 | 278 | |
From Investments | Rs m | -168 | -402 | -207 | -1,967 | -1,011 | |
From Financial Activity | Rs m | 174 | 100 | -47 | 2,350 | 378 | |
Net Cashflow | Rs m | 80 | -49 | -57 | 585 | -357 |
Share Holding
Shareholding as on Mar 2024
|
Company Information
|
CHM: Chintan Nitinkumar Shah | COMP SEC: Apurva Dubey | YEAR OF INC: 1996 | BSE CODE: 543321 | FV (Rs): 10 | DIV YIELD (%): 0.2 |
More Chemicals & Pesticides Company Fact Sheets: UPL PIDILITE INDUSTRIES BALAJI AMINES BODAL CHEMICALS INDIA PESTICIDES
Compare TATVA CHINTAN PHARMA With: UPL PIDILITE INDUSTRIES BALAJI AMINES BODAL CHEMICALS INDIA PESTICIDES
Indian share markets Slipped further as the session progressed and ended the day weak.